₱0.00
-
By: health
-
August 2, 2019
FDA approves Vyleesi to treat low sexual desire in women
The FDA has approved a new drug, Vyleesi , to treat hypoactive sexual desire disorder (HSDD) in women who haven’t yet gone through menopause. Vyleesi is only the second drug that’s been approved for the treatment of HSDD. The first was Addyi, which was approved in 2015.
Addyi is a pill that must be taken every day. The most common side effects include dizziness, nausea, tiredness, dry mouth, and problems with sleep. Drinking alcohol too close in time to taking a dose of Addyi can increase the risk of severe low blood pressure and fainting.
Vyleesi, on the other hand, is a shot you give yourself rather than a pill, and it’s used only when you’re going to have sex. It’s taken at least 45 minutes before sex. The most common side effects of Vyleesi are nausea and vomiting, flushing, headache, and reactions at the site of the injection. In trials, Vyleesi increased blood pressure.
If you are looking for help with low sexual desire, talk to your health care provider. There are many possible causes for low desire and there may be things you can do. Your provider can also tell you more about these medications and help you figure out if one of them is right for you.
Related Posts
Tags
Abortion
Abortion articles
Affordable Care Act
better sex
birth control
birth control patch
birth control pill
birth control ring
boundaries and consent
communication
condom
cost & insurance
culture
dating and hookups
emergency contraception
frisky friday
get on top
guys
Health
health care
history and culture
horoscopes
how-to
identity & inspiration
implant (Nexplanon)
inspiration
IUD
news
periods
pregnancy and fertility
problem solving
provider perspective
public policy
real story
relationships
romance
safety
self love and body positivity
sex and relationships
sex and science
sexual health & wellness
sexually transmitted infections (STIs/STDs)
shot (Depo-Provera)
side effects
video
Leave a comment